发明名称 HUMAN ANTIBODIES BINDING HUMAN TUMOUR NECROTIC FACTOR ALPHA
摘要 The invention relates to human antibodies, preferably recombinant human antibodies which are specifically bound to human tumour necrotic factor alpha(TNFalpha). The antibodies have high afinity to hTNFalpha, e.g. Kd = 10-8 M or less, low hTNFalpha dissociate velocity, e.g. Koff = 10-3sec-1 or less, and neutralize the hTNFalpha activity in vitro and in vivo. Antibody of this invention can be an antibody with its full length or its antigene-binding part. The antibodies or parts thereof are applicable for the detection of hTNFalpha and for the inhibition of hTNFalpha activity, for example in patients suffering from indispositions where the hTNFalpha activity is harmfull. The invention also relates to nucleinic acids, vectors and host cells for the expression of recombinant human antibodies and to methods for their synthetization.
申请公布号 BG64564(B1) 申请公布日期 2005.07.29
申请号 BG19980102755 申请日期 1998.09.08
申请人 BASF AKTIENGESELLSCHAFT 发明人 SALFELD JOCHEN;ALLEN DEBORAH;KAYMAKCALAN ZEHRA;LABKOVSKY BORIS;MANKOVICH JOHN;MCGUINNESS BRIAN;ROBERTS ANDREW;SAKORAFAS PAUL;HOOGENBOOM HENDRICUS;SCHOENHAUT DAVID;VAUGHAN TRISTAN;WHITE MICHAEL;WILTON ALISON
分类号 C12N15/09;A61K31/00;A61K31/40;A61K31/403;A61K31/404;A61K31/415;A61K31/4164;A61K31/4178;A61K31/505;A61K31/517;A61K31/52;A61K31/529;A61K31/57;A61K31/573;A61K31/675;A61K38/00;A61K38/04;A61K38/16;A61K39/39;A61K39/395;A61P1/00;A61P1/04;A61P1/16;A61P3/10;A61P7/00;A61P7/04;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P11/16;A61P13/12;A61P17/00;A61P17/02;A61P19/02;A61P19/06;A61P25/00;A61P27/02;A61P29/02;A61P31/00;A61P31/04;A61P31/12;A61P31/18;A61P33/06;A61P35/00;A61P35/04;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P39/02;C07K16/24;C12N1/21;C12N5/10;C12P21/08;G01N33/53;G01N33/543;G01N33/564;G01N33/576;G01N33/68;(IPC1-7):C07K16/24;C12N15/64;C12N15/13 主分类号 C12N15/09
代理机构 代理人
主权项
地址